美国10月标普全球制造业PMI初值 56，预期55.5，前值55.9。

US S&P Global preliminary Services PMI for October 57.9, expected 58.0, prior 58.8.

Moderna (MRNA.O) shares tumbled as much as nearly 25% intraday on Thursday; Merck (MRK.N) fell 3.7%. Data from the experimental cancer vaccine the two firms are developing appears to have been posted early on medical site Oncology Central and was subsequently removed; the results had been scheduled for presentation at the European Society for Medical Oncology (ESMO) meeting on Saturday. The briefly posted data suggested the vaccine, administered with Merck’s Keytruda, reduced the risk of melanoma recurrence or death. Both companies had previously said the Phase III trial met its primary endpoint but have not published detailed results.